Intersect ENT is committed to developing clinically proven therapy solutions that enable ear, nose, and throat (ENT) physicians to solve clinical challenges and improve the quality of life for patients.

Innovation and creativity are driving forces for our company. The company has protected intellectual property with the following issued U.S. patents and has more than 75 patents and pending applications worldwide.

17 Issued U.S. Patents
US 5,897,521
US 6,543,452
US 7,544,192
US 7,547,323
US 7,662,141
US 7,662,142
US 7,686,798
US 7,691,094
US 7,713,255
US 7,951,130
US 7,951,131
US 7,951,132
US 7,951,133
US 7,951,134
US 7,951,135
US 8,025,635
US 8,109,918